Renewable Energy and Alternative Fuels Stocks Rally as Deal to Avoid “Fiscal Cliff” Extends Industry Tax Credits

Five Star Equities Provides Stock Research on BioFuel Energy and KiOR

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Impax Laboratories and Spectrum Pharmaceuticals

Continue Reading

Amyris and Solazyme Shares Surge as Alternative Fuels Tax Credit Extended Through 2013

Five Star Equities Provides Stock Research on Amyris and Solazyme

Continue Reading

Renewable Energy and Alternative Fuels Stocks Rally as Deal to Avoid “Fiscal Cliff” Extends Industry Tax Credits

Five Star Equities Provides Stock Research on Renewable Energy Group and Gevo

Continue Reading

Wind Power Companies Look to Benefit as American Taxpayer Relief Act Extends Wind Production Tax Credits

Five Star Equities Provides Stock Research on Broadwind Energy and Kaydon

Continue Reading

Biotech Industry Experiencing More FDA New Drug Approvals in 2012

Five Star Equities Provides Stock Research on Acorda Therapeutics and Peregrine Pharmaceuticals

Continue Reading

China-s Sets First Round of 2013 Rare Earth Exports 27% Below 2012

Five Star Equities Provides Stock Research on Molycorp and Lynas

Continue Reading

Rare Industry Continues to Struggle With Low Prices and New Supplies — China Sets 2013 Rare Earth Exports Quotas

Five Star Equities Provides Stock Research on Rare Element Resources and Quest Rare Minerals

Continue Reading

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on Progenics Pharmaceuticals and Vical

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Incyte and Oncolytics Biotech

Continue Reading